Healthcare Billionaire, His Daughter, and a Family Office Spin-Off Backing an X-Ray Vision Startup

Why It Matters

The investment highlights how family offices are increasingly channeling capital into advanced surgical imaging, a sector poised for rapid growth as hospitals adopt AI‑driven tools. It also cements the Kiani family’s influence in shaping next‑generation medical technology markets.

Key Takeaways

• Elderberry Ventures launched 2025, focusing on life‑science tech
• Joe Kiani’s daughter leads new investment firm, continuing family’s health focus
• First portfolio company: X‑ray vision startup for intra‑operative imaging
• Chief investment officer of Kiani Preserve backs Elderberry’s early‑stage deals
• Investment underscores growing private capital interest in surgical AI and imaging

Pulse Analysis

Family offices have evolved from passive wealth custodians to active venture builders, especially in health‑care where deep industry knowledge translates into strategic capital deployment. Joe Kiani, co‑founder of a leading pulse‑oximetry company, has leveraged his legacy to create a platform that blends his entrepreneurial instincts with the next generation’s ambition. By appointing his daughter as the public face and pairing her with the seasoned chief investment officer of Kiani Preserve, the group ensures both continuity and fresh perspective in deal sourcing.

Elderberry Ventures, the spin‑off launched in 2025, zeroes in on early‑stage life‑science innovations that promise to disrupt clinical workflows. Its mandate emphasizes technologies that can accelerate diagnosis, improve patient outcomes, and generate scalable revenue streams. The firm’s inaugural investment—a startup developing X‑ray vision systems capable of delivering real‑time, high‑resolution images during surgery—exemplifies this focus. Such intra‑operative imaging tools can reduce operative time, lower complication rates, and enable minimally invasive techniques, aligning with hospital cost‑containment goals.

The broader market for AI‑enhanced surgical imaging is projected to exceed $5 billion by 2030, driven by rising demand for precision medicine and the digital transformation of operating rooms. Private capital, particularly from family offices with sector expertise, is filling the funding gap left by traditional venture firms wary of long development cycles. Kiani’s entry not only validates the commercial potential of X‑ray vision platforms but also signals a wave of strategic, family‑office‑backed investments that could accelerate the adoption of next‑generation surgical technologies across the United States and beyond.